Comparative effects of flurbiprofen and fentanyl on natural killer cell cytotoxicity, lymphocyte subsets and cytokine concentrations in post-surgical intensive care unit patients: Prospective, randomized study

Journal of Anesthesia

Volumn 27, Issue 5, 2013, Pages 676-683

  Narahara, Hajime ^a   Kadoi, Yuji ^a   Hinohara, Hiroshi ^a   Kunimoto, Fumio ^a   Saito, Shigeru ^a  

^a GUNMA UNIVERSITY HOSPITAL   (Japan)

Author keywords

Fentanyl; Flurbiprofen; Long term sedation; Natural killer cell cytotoxicity

Indexed keywords

FENTANYL; FLURBIPROFEN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROPOFOL; REMIFENTANIL; ROCURONIUM; SEVOFLURANE; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; FEMALE; HUMAN; INTENSIVE CARE UNIT; LYMPHOCYTE SUBPOPULATION; MALE; NATURAL KILLER CELL MEDIATED CYTOTOXICITY; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; SEDATION;

AGED; ANALGESICS; ANESTHETICS, INTRAVENOUS; CELL LINE, TUMOR; FEMALE; FENTANYL; FLURBIPROFEN; HUMANS; INTENSIVE CARE UNITS; INTERLEUKINS; K562 CELLS; KILLER CELLS, NATURAL; LYMPHOCYTE SUBSETS; MALE; MIDDLE AGED; POSTOPERATIVE PERIOD; PROPOFOL; PROSPECTIVE STUDIES; SURGICAL PROCEDURES, OPERATIVE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84885949413     PISSN: 09138668     EISSN: 14388359     Source Type: Journal    
DOI: 10.1007/s00540-013-1597-5     Document Type: Article

References (33)

1. Meakins JL. Surgeons, surgery, and immunomodulation. Arch Surg. 1991;126:494-8.
2. Slade MS, Simmons RL, Yunis E, Greenberg LJ. Immunodepression after major surgery in normal patients. Surgery (St. Louis). 1975;78:363-72.
3. Ogawa K, Hirai M, Katsube T, Murayama M, Hamaguchi K, Shimakawa T, Naritake Y, Hosokawa T, Kajiwara T. Suppression of cellular immunity by surgical stress. Surgery (St. Louis). 2000;127:329-36.
4. Kurosawa S, Kato M. Anesthetics, immune cells, and immune responses. J Anesth. 2008;22:263-77.
5. Watling SM, Dasta JF, Seidl EC. Sedatives, analgesics, and paralytics in the ICU. Ann Pharmacother. 1997;31:148-53.
6. Dasta JF, Fuhrman TM, McCandles C. Patterns of prescribing and administering drugs for agitation and pain in patients in a surgical intensive care unit. Crit Care Med. 1994;22:974-80.
7. Eisenstein TK, Hillburger ME. Opioid modulation of immune responses: effects on phagocyte and lymphoid cell population. J Neuroimmunol. 1998;83:36-44.
8. Yeager MP, Colacchio TA, Yu CT, Hildebrandt L, Howell AL, Weiss J, Guyre PM. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology. 1995;83:500-8.
9. Soliman HM, Melot C, Vincent JL. Sedative and analgesic practice in the intensive care unit: the results of a European survey. Br J Anaesth. 2001;87:186-92.
10. Kadoi Y, Hinohara H, Kunimoto F, Saito S, Goto F. Fentanyl-induced hemodynamic changes after esophagectomy or cardiac surgery. J Clin Anesth. 2005;17:598-603.
11. Shavit Y, Ben-Eliyahu S, Zeidel A, Beilin B. Effects of fentanyl on natural killer cell activity and on resistance to tumor metastasis in rats. Dose and timing study. Neuroimmunomodulation. 2004;11:255-60.
12. Beilin B, Shavit Y, Hart J, Mordashov B, Cohn S, Notti I, Bessler H. Effects of anesthesia based on large versus small doses of fentanyl on natural killer cell cytotoxicity in the perioperative period. Anesth Analg. 1996;82:492-7.
13. Hussain M, Javeed A, Ashraf M, Al-Zaubai N, Stewart A, Mukhtar MM. Non-steroidal anti-inflammatory drugs, tumour immunity and immunotherapy. Pharmacol Res. 2012;66:7-18.
14. Kress JP, Hall JB. Sedation in the mechanically ventilated patient. Crit Care Med. 2006;34:2541-6.
15. Payen JF, Bru O, Bosson JL, Lagrasta A, Novel E, Deschaux I, Lavagne P, Jacquot C. Assessing pain in critically ill sedated patients by using a behavioral pain scale. Crit Care Med. 2001;29:2258-63.
16. Yokoyama M, Itano Y, Mizobuchi S, Nakatsuka H, Kaku R, Takashima T, Hirakawa M. The effects of epidural block on the distribution of lymphocyte subsets and natural killer cell activity in patients with and without pain. Anesth Analg. 2001;92:463-9.
17. Volk T, Schenk M, Voigt K, Tohtz S, Putzier M, Kox WJ. Postoperative epidural anesthesia preserves lymphocyte, but not monocyte, immune function after major spine surgery. Anesth Analg. 2004;98:1086-92.
18. Patel SB, Kress JP. Sedation and analgesia in the mechanically ventilated patient. Am J Respir Crit Care Med. 2012;185:486-97.
19. Sanders RD, Hussell T, Maze M. Sedation & immunomodulation. Crit Care Clin. 2009;25:551-70.
20. Carr DJ, Rogers TJ, Weber RJ. The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis. Proc Soc Exp Biol Med. 1996;213:248-57.
21. Lysle DT, Conssons ME, Watts VJ, Bennett EH, Dykstra LA. Morphine-induced alterations of immune status: dose dependency, compartment specificity and antagonism by naltrexone. J Pharmacol Exp Ther. 1993;265:1071-8.
22. Yardeni IX, Beilin B, Mayburd E, Alcalay Y, Bessler H. Relationship between fentanyl dosage and immune function in the postoperative period. J Opioid Manag. 2008;4:27-33.
23. Jacobs R, Karst M, Scheinichen D, Bevilacqua C, Schneider U, Heine J, Schedlowski M, Schmidt RE. Effects of fentanyl on cellular immune functions in man. Int J Immunopharmacol. 1999;21:445-54.
24. Yeager MP, Procopio MA, DeLeo JA, Arruda JL, Hildebrandt L, Howell AL. Intravenous fentanyl increases natural killer cell cytotoxicity and circulating CD16+ lymphocytes in humans. Anesth Analg. 2002;94:94-9.
25. Schneemilch CE, Hachenberg T, Ansorge S, Ittenson A, Bank U. Effects of different anaesthetic agents on immune cell function in vitro. Eur J Anaesthesiol. 2005;22:616-23.
26. Inada T, Kubo K, Shingu K. Possible link between cyclooxygenase- inhibiting and antitumor properties of propofol. J Anesth. 2011;25:569-75.
27. Kundu N, Walser TC, Ma X, Fulton AM. Cyclooxygenase inhibitors modulate NK activities that control metastatic disease. Cancer Immunol Immunother. 2005;54:981-7.
28. Benish M, Bartal I, Goldfarb Y, Levi B, Avraham R, Raz A, Ben-Eliyahu S. Perioperative use of β-blockers and COX-2 inhibitors may improve immune competence and reduce the risk of tumor. Ann Surg Oncol. 2008;15:2042-52.
29. Bastami S, Norling C, Trinks C, Holmlund B, Walz TM, Ahlner J, Uppugunduri S. Inhibitory effect of opiates on LPS mediated release of TNF and IL-8. Acta Oncol. 2012. doi: 10.3109/0284186X.2012.737932
30. Inaoka M, Kimishima M, Takahashi R, Shiohara T. Non-steroidal anti-inflammatory drugs selectively inhibit cytokine production by NK cells and gamma delta T cells. Exp Dermatol. 2006;15:981-90.
31. Nelson CJ, Dykstra LA, Lysle DT. Comparison of the time course of morphine's analgesic and immunologic effects. Anesth Analg. 1997;85:620-6.
32. Melamed R, Bar-Yosef S, Shakhar G, Shakhar K, Ben-Eliyahu S. Suppression of natural killer cell activity and promotion of tumor metastasis by ketamine, thiopental, and halothane, but not by propofol: mediating mechanisms and prophylactic measures. Anesth Analg. 2003;97:1331-9.
33. Cronin AJ, Aucutt-Walter NM, Budinetz T, Bonafide CP, DiVittore NA, Gordin V, Schuler HG, Bonneau RH. Low-dose remifentanil infusion does not impair natural killer cell function in healthy volunteers. Br J Anaesth. 2003;91:805-9.